anti cancer

Vincristine Sulphate Injection Oncovin 1 mg – India to UK Pharmaceutical Export Service Pharmaceutical Supplier UK – Vincristine Sulphate Injection Are you looking for a UK pharmaceutical supplier to answer questions about Oncovin 1 mg Vincristine Sulphate Injection? We are based in India and our pharmaceutical export service caters to B2B pharmaceutical enquiries from authorised healthcare, procurement and pharmaceutical organisations across the United Kingdom. We support pharmaceutical export enquiries across London, Birmingham, Manchester, Glasgow, Liverpool and Leeds subject to applicable UK import, licensing and product requirements. Vincristine Sulphate Injection Oncovin 1 mg Product: Oncovin (vincristine sulphate) Injection 1mg Active Ingredient: Vincristine sulphate. Strength: 1mg Strength: Injection Therapeutic class: Vinca alkaloid/antineoplastic agent India Export Source: Target market UK Vinca alkaloid, vincristine sulphate, antineoplastic agent. Vincristine sulphate injection is described in the UK product information as a medicine used in specialist cancer treatment and is for intravenous use only. Given vincristine’s status as a cytotoxic medicine with important precautions for administration and handling, product supply and importation should be undertaken by appropriately licensed pharmaceutical organisations and qualified healthcare professionals. Description Product Oncovin 1 mg Injection Vincristine Sulphate is a pharmaceutical formulation of vincristine sulphate, an antineoplastic vinca alkaloid. Vincristine acts on microtubules to inhibit cell division and is included in oncology treatment protocols. The UK Summary of Product Characteristics for vincristine sulphate injection provides therapeutic use in a range of haematological malignancies and solid tumours and provides detailed professional information concerning administration, contraindications, warnings and handling. Pharmaceutical Export Services UK from India Our India to UK pharmaceutical export services are for genuine B2B pharmaceutical enquiries for sourcing and exporting pharmaceutical products. Subject to applicable regulations and documentation. The requirements for importing into the UK may depend on the regulatory status of the medicine. To import human medicines into the UK you may need the appropriate licences, says the MHRA. This includes a Wholesale Distribution Authorisation, manufacturer/importer authorisation and where applicable a marketing authorisation. Pharmaceutical Export Enquiries (UK-wide) We accept pharmaceutical export enquiries from organisations located in: London • Birmingham • Manchester • • Glasgow. • Liverpool • Leeds This is a professional B2B service and not a direct-to-patient sale. Product Inquiry – Pharmaceutical Supplier UK If you are an organization seeking information on Oncovin 1 mg Vincristine Sulphate Injection or other pharmaceutical products for the UK market, please contact our export team with your product requirements and destination details. Availability, regulatory paperwork, export eligibility and commercial terms are to be confirmed on an individual inquiry basis. Get in touch with our Export Team Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 WhatsApp: Chat to us on WhatsApp+919673008130 UK Pharmaceutical Importation Compliance Medicines imported into the UK are regulated. Requirements vary depending on a number of factors, including whether the medicine is licensed or unlicensed and the country it is imported from, says the MHRA. UK wholesalers supplying human medicines usually require the relevant wholesale distribution authorisation and there may be additional requirements for imports and marketing authorisations. UK organisations should check the relevant requirements before placing an import or supply order. The MHRA also keeps registers of licensed wholesale distribution sites and other pharmaceutical regulatory information. Oncovin 1 mg Vincristine Injection | UK Pharmaceutical Supplier India to UK pharmaceutical export services for Oncovin 1 mg Vincristine Sulphate Injection. Professional B2B pharmaceutical enquiries across London, Birmingham and the UK

Neophos 1000 mg Cyclophosphamide Injection Vial - Pharmaceuticals Exporter from India to United Kingdom Neophos 1000 mg Cyclophosphamide Injection Vial is a drug that contains cyclophosphamide , an alkylating agent used in specialist medical settings. Based in India, our pharmaceutical export service helps qualified pharmaceutical buyers, distributors, wholesalers and healthcare procurement organisations looking for information on pharmaceutical supply from India to the UK. Pharmaceutical Export Services from India to UK We handle pharmaceutical export enquiries from all over the United Kingdom including: London Birmingham Manchester Liverpool Leeds Glasgow Our India to UK Pharmaceutical Export Services are for professional B2B enquiries and can help with product information, availability enquiries, documentation requirements and export co-ordination, subject to applicable Indian and UK Regulatory Requirements. Product Specifications – Cyclophosphamide Injection Vial Neophos 1000 mg Brand: Neophos 1000 mg Injection Active ingredient: Cyclophosphamide Strength 1000 mg Type of administration: Powder for solution for injection/infusion Product group: Cytotoxic drug / Antineoplastics Packaging Vial, as per manufacturer and presentation in the market Supply: Export enquiries for pharmaceuticals B2B Country of Origin: India Prior to ordering, the supplier should be contacted for product specifications, pack presentation, registration status, batch documentation and availability. Pharmaceutical export support from India to the UK Looking for a pharmaceutical supplier for UK procurement? We provide export inquiry support from India for pharmaceutical products including specialist medicines such as cyclophosphamide injection subject to applicable licensing, product registration and import requirements. UK importers should independently verify the regulatory status of any medicinal product prior to importation or supply. UK importers may need to hold appropriate authorisations, including a Wholesale Distribution Authorisation (WDA(H)), manufacturer/importer authorisation or other appropriate permissions depending on the product and circumstances, according to the MHRA. For unlicensed medicines further MHRA requirements and notification procedures may apply. Cyclophosphamide Injection Manufacturer India If you are looking for a supplier of cyclophosphamide injection from India, then contact us for product and pharmaceutical export enquiries. We can provide the requirements for Neophos 1000 mg cyclophosphamide injection vial, if available, manufacturer documentation, destination-market requirements and applicable regulatory approvals. Cyclophosphamide is a cytotoxic pharmaceutical product and a prescription medicine. It should be dealt with, provided and administered only by appropriately authorised and qualified professionals. India to UK Pharmaceutical Exporter We are an India based pharmaceutical export contact supporting B2B enquiries from buyers and pharmaceutical organisations in London, Birmingham, Manchester, Liverpool, Leeds and Glasgow. We do not sell medicine direct to consumers, our services are geared toward professional pharmaceutical procurement and export queries. For Enquiries on Pharmaceutical Exports Website: medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Phone / WhatsApp: +91 9673008130 Neophos 1000 mg Cyclophosphamide Injection India to UK Pharmaceutical Exporter Buy Neophos 1000 mg cyclophosphamide injection vial and India to UK pharmaceutical export services for qualified pharmaceutical buyers and importers.

Learn about MITOMYCIN INJECTION 2 mg, an anticancer medicine used for the treatment of various cancers. Explore indications, mechanism of action, dosage, side effects, storage, safety precautions, and product profile. Discover quality pharmaceutical products from Primecare Impex. MITOMYCIN INJECTION 2 mg – Complete Product Profile MITOMYCIN INJECTION 2 mg is a prescription anticancer medicine containing Mitomycin 2 mg, a potent antineoplastic antibiotic widely used in oncology. It works by preventing cancer cells from growing and multiplying, helping slow or stop tumor progression. Administration should always be supervised by qualified oncology professionals in an appropriate clinical setting. MITOMYCIN has been used for many years in cancer treatment protocols and is often administered either alone or in combination with other chemotherapy medicines depending on the cancer type, stage, and the treating oncologist's recommendations. Product Profile Product Name MITOMYCIN INJECTION 2 mg Generic Name Mitomycin Strength 2 mg Dosage Form Sterile Injection Packing 1 Vial Therapeutic Category Anticancer Medicine Route of Administration Intravenous (IV) – As prescribed by an oncologist Storage Store according to label instructions and protect from excessive heat and light Prescription Status Prescription Only Medicine MITOMYCIN INJECTION 2 mg is prescribed by oncology specialists as part of treatment plans for selected cancers. Clinical use depends on the patient's diagnosis, overall health, treatment history, and physician assessment. It may be used in the management of: Bladder Cancer Gastric Cancer Pancreatic Cancer Colorectal Cancer Breast Cancer (selected treatment protocols) Lung Cancer (selected treatment protocols) Cervical Cancer (selected treatment protocols) Esophageal Cancer Anal Cancer Head and Neck Cancers In clinical practice, Mitomycin may be administered: As a single-agent chemotherapy In combination chemotherapy regimens Before surgery After surgery Alongside radiation therapy in selected cases Treatment decisions should always be individualized by an oncology specialist. 2. Mechanism of Action – How MITOMYCIN Works MITOMYCIN belongs to the class of antitumor antibiotics. After administration, it becomes activated within cells and works by: DNA Cross-Linking The medicine forms cross-links between DNA strands. Prevents DNA Replication Cancer cells are unable to duplicate their DNA efficiently. Blocks Cell Division Rapidly growing tumor cells cannot continue normal cell division. Induces Cancer Cell Death Damaged cancer cells undergo programmed cell death (apoptosis). Slows Tumor Growth The medicine helps reduce cancer progression by limiting tumor cell multiplication. MITOMYCIN INJECTION 2 mg should only be administered by experienced healthcare professionals. General administration guidance includes: Intravenous infusion only unless otherwise directed by oncology protocols. Dosage varies according to: Cancer type Body surface area (BSA) Laboratory values Kidney function Bone marrow function Previous chemotherapy exposure Adequate hydration may be recommended depending on the treatment protocol. Treatment cycles are determined by the oncologist. Patients require routine laboratory monitoring throughout therapy. Never self-administer this medicine. Why Choose Primecare Impex Primecare Impex is engaged in supplying pharmaceutical products with a focus on quality, professional service, and documentation support. Key highlights include: Quality-focused pharmaceutical sourcing Wide range of pharmaceutical products Professional export documentation support Secure packaging Responsive customer support Reliable supply network Timely communication Commitment to product quality standards Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: Chat on WhatsApp Mitomycin Injection 2 mg in Washington Mitomycin Injection 2 mg information Washington Mitomycin chemotherapy medicine Washington Mitomycin Injection 2 mg in London Mitomycin oncology medicine London Mitomycin Injection 2 mg United Kingdom Mitomycin Injection 2 mg Riyadh Mitomycin cancer medicine Saudi Arabia Mitomycin Injection 2 mg Canberra Mitomycin oncology medicine Australia Mitomycin Injection 2 mg UAE Mitomycin cancer treatment information UAE Mitomycin Injection 2 mg Kingston Jamaica Mitomycin oncology medicine Jamaica

Mitocin Injection 40 mg (Mitomycin Injection 40 MG): Complete Patient Information Guide Cancer treatment has advanced significantly with specialized medicines that help slow or stop the growth of cancer cells. Mitocin Injection 40 mg (Mitomycin Injection 40 MG) is an anticancer medicine used under the supervision of qualified oncology specialists. It plays an important role in treating selected cancers by preventing the multiplication of abnormal cells. This guide explains the medicine, how it works, who may receive it, administration methods, possible side effects, storage requirements, and important safety information for patients and caregivers. What is Mitocin Injection 40 mg? Mitocin Injection 40 mg contains Mitomycin, an anticancer medicine belonging to the class of antitumor antibiotics. Although originally derived from Streptomyces caespitosus, Mitomycin acts as a chemotherapy medicine that interferes with the DNA of cancer cells, helping stop their growth and spread. It is administered only by qualified healthcare professionals in hospitals or specialized cancer treatment centers. Product Details Product Name: Mitocin Injection 40 mg Generic Name: Mitomycin Injection Strength: 40 MG Packing: 1 Vial Dosage Form: Sterile Injection Category: Anticancer Medicine Route: Intravenous (IV) or as directed by an oncologist Prescription Required: Yes itocin Injection 40 mg may be prescribed by an oncologist as part of treatment plans for selected cancers. Treatment decisions depend on the patient's diagnosis, overall health, and clinical evaluation. It may be used in the management of: Bladder cancer Stomach (gastric) cancer Pancreatic cancer Breast cancer (selected cases) Colorectal cancer Esophageal cancer Cervical cancer Anal cancer Certain gastrointestinal cancers In some situations, oncologists may combine Mitomycin with other chemotherapy medicines or radiation therapy, depending on current clinical guidelines. Important: The specific treatment plan should always be determined by a qualified healthcare professional. Mechanism of Action: How Mitocin Injection 40 mg Works Mitomycin works by targeting rapidly dividing cancer cells. Its mechanism includes: DNA Cross-Linking Mitomycin creates cross-links between DNA strands. This prevents: DNA replication Cell division Cancer cell multiplication Inhibition of Cancer Growth Without proper DNA replication: Cancer cells stop growing. Cell division slows. Damaged cancer cells eventually die. Cell Cycle Effect Mitomycin affects cancer cells during multiple phases of the cell cycle, making it effective against several rapidly dividing tumors. Benefits of Mitocin Injection 40 mg Potential benefits include: Helps slow tumor progression Supports cancer treatment plans May reduce cancer cell multiplication Used in combination chemotherapy protocols Can improve disease management when prescribed appropriately Administered under specialist medical supervision Patients should inform their healthcare provider if they have: Kidney disease Liver disease Previous chemotherapy Lung disease Active infection Bleeding disorders Pregnancy or breastfeeding concerns Is Mitocin Injection 40 mg a chemotherapy medicine? Yes. Mitomycin is an anticancer chemotherapy medicine used under the supervision of oncology specialists. Can patients administer this injection at home? No. It should only be administered by qualified healthcare professionals in an appropriate clinical setting. Does everyone experience side effects? No. Side effects vary among individuals, and healthcare providers monitor patients throughout treatment. Can Mitocin Injection be used alone? Treatment plans vary. Some patients may receive Mitomycin alone, while others may receive it as part of combination therapy, depending on medical evaluation. Why are regular blood tests important? Blood tests help monitor blood cell counts and organ function during treatment, allowing healthcare providers to adjust therapy if needed. Why Choose Primecare Impex? Primecare Impex is committed to supplying quality pharmaceutical products while emphasizing regulatory compliance, product integrity, and customer support. Key strengths include: Quality-focused pharmaceutical sourcing Export experience across multiple international markets Reliable packaging standards Professional customer assistance Commitment to product authenticity Responsive communication Global Availability Information about Mitocin Injection 40 mg is relevant to readers seeking healthcare information in: Washington London, UK Riyadh, Saudi Arabia Canberra, Australia United Arab Emirates (UAE) Kingston, Jamaica Contact Primecare Impex Primecare Impex – Pharmaceutical Exporter from India 🌐 Website: www.medicineexporterfromindia.com 📧 Email: raakeshkashiwar@gmail.com 📞 WhatsApp: +91 9673008130 📲 WhatsApp: https://wa.me/919673008130

Learn about MITOMYCIN-C Kyowa 40 mg for Injection, its clinical indications, mechanism of action, dosage, administration, safety precautions, storage guidelines, and product profile. Discover trusted pharmaceutical export information from Primecare Impex serving healthcare customers in Washington, London, Riyadh, Canberra, UAE, and Kingston. MITOMYCIN-C Kyowa 40 mg for Injection MITOMYCIN-C Kyowa 40 mg for Injection MITOMYCIN-C Kyowa 40 mg for Injection is an antineoplastic (anticancer) medicine used in oncology for the treatment of selected malignant conditions. Mitomycin-C belongs to the class of antitumor antibiotics and is administered only under the supervision of qualified healthcare professionals experienced in cancer chemotherapy. Primecare Impex provides reliable pharmaceutical export services for genuine oncology medicines while maintaining quality standards and proper documentation for international healthcare requirements. Product Name: MITOMYCIN-C Kyowa 40 mg for Injection Generic Name: Mitomycin-C Strength: 40 mg Dosage Form: Sterile Powder for Injection Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine Route of Administration: Intravenous administration by trained healthcare professionals What is MITOMYCIN-C Kyowa 40 mg? MITOMYCIN-C is a cytotoxic chemotherapy medicine widely used in oncology. It is prescribed as part of individualized cancer treatment plans depending on the patient's diagnosis, disease stage, previous therapies, and overall health condition. The medicine is used in hospitals and specialized oncology centers where patients receive continuous medical monitoring during treatment. MITOMYCIN-C may be prescribed by oncologists for selected cancers where clinically appropriate. Common clinical applications include: Gastric cancer Pancreatic cancer Bladder cancer Colorectal cancer Breast cancer (selected treatment protocols) Head and neck cancers Esophageal cancer Cervical cancer Anal carcinoma Combination chemotherapy protocols Intravesical treatment for superficial bladder cancer (where indicated) Treatment decisions are individualized by the treating oncology specialist. How MITOMYCIN-C Works MITOMYCIN-C acts by interfering with DNA synthesis inside rapidly dividing cancer cells. Its mechanism includes: Cross-linking DNA strands Inhibiting DNA replication Preventing cancer cell multiplication Inducing programmed cell death (apoptosis) Reducing tumor growth Supporting combination chemotherapy protocols Because cancer cells divide rapidly, they are particularly susceptible to DNA damage caused by Mitomycin-C. MITOMYCIN-C should only be administered in hospitals or oncology treatment centers. General administration includes: Intravenous infusion Prepared using sterile techniques Dose determined by oncologist Based on: Body surface area (BSA) Kidney function Liver function Blood counts Previous chemotherapy Overall treatment response Patients should never self-administer this medicine. Safety, Side Effects an Is MITOMYCIN-C an antibiotic? It is classified as an antitumor antibiotic used in cancer treatment rather than for bacterial infections. Can patients administer MITOMYCIN-C at home? No. Administration should only be performed by qualified healthcare professionals. Is regular monitoring required? Yes. Blood counts and organ function are commonly monitored throughout treatment. Does dosage vary? Yes. Dosage is individualized by the treating oncologist. Why Choose Primecare Impex? Primecare Impex is committed to supporting access to quality pharmaceutical products through professional export services. Key strengths include: Genuine pharmaceutical products Secure export packaging International shipping support Responsive customer assistance Quality-focused handling Assistance with export documentation Timely communication Experience in pharmaceutical exports Global Availability Information about MITOMYCIN-C Kyowa 40 mg is frequently sought by healthcare professionals and organizations in: Washington London, United Kingdom Riyadh, Saudi Arabia Canberra, Australia United Arab Emirates Kingston, Jamaica Availability depends on local regulatory requirements and import regulations. Contact Primecare Impex Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130 Business Type: Exporter | Supplier | Distributor

Learn about ALKACEL 50 mg (Melphalan Injection Lyophilized Powder 50 mg), its uses, dosage, mechanism of action, side effects, storage, and safety information. Find comprehensive patient information from Primecare Impex. ALKACEL 50 mg (Melphalan Injection Lyophilized Powder 50 mg) Complete Patient Information Guide ALKACEL 50 mg contains Melphalan Injection Lyophilized Powder 50 mg, a prescription anticancer medicine used under the supervision of qualified oncology specialists. Melphalan belongs to the alkylating agent class of chemotherapy medicines and is widely used in the treatment of specific blood cancers and other malignancies. The medicine works by interfering with the DNA of rapidly dividing cancer cells, helping slow or stop their growth. Treatment with ALKACEL 50 mg should always be performed in hospitals or specialized oncology centers where patients can be carefully monitored by experienced healthcare professionals. What is ALKACEL 50 mg? ALKACEL 50 mg is a sterile lyophilized powder containing Melphalan 50 mg, which is reconstituted before intravenous administration. Melphalan has been an important chemotherapy medicine for several decades and remains an essential treatment option in various oncology protocols worldwide. It is generally administered as part of individualized chemotherapy regimens based on: Cancer type Disease stage Body surface area Kidney function Overall health condition Previous chemotherapy history Clinical Indications & Uses of ALKACEL 50 mg Doctors may prescribe ALKACEL 50 mg for several types of cancer depending on the patient's condition. Multiple Myeloma One of the most common indications for Melphalan Injection is multiple myeloma, a cancer affecting plasma cells within the bone marrow. ALKACEL 50 mg may be used: Before stem cell transplantation High-dose chemotherapy protocols Combination therapy Hospital-based oncology treatment Ovarian Cancer Melphalan may also be recommended for selected patients diagnosed with ovarian carcinoma when determined appropriate by the treating oncologist. Bone Marrow Transplant Conditioning High-dose Melphalan is commonly used before autologous stem cell transplantation to eliminate cancer cells before transplantation. Other Physician-Directed Uses Depending upon oncology guidelines and clinical judgment, Melphalan may be used in additional cancer treatment protocols where considered appropriate by specialists. How ALKACEL 50 mg Works Understanding the treatment process helps patients know what to expect. Step 1 The medicine enters the bloodstream through intravenous administration. Step 2 Melphalan circulates throughout the body. Step 3 The drug reaches rapidly dividing cancer cells. Step 4 Melphalan binds directly to cancer cell DNA. Step 5 DNA replication becomes disrupted. Step 6 Cancer cells lose their ability to multiply. Step 7 Damaged cancer cells gradually undergo programmed cell death (apoptosis). Step 8 Tumor burden decreases over multiple treatment cycles under physician supervision. How ALKACEL 50 mg Works Melphalan belongs to the class of medicines known as alkylating agents. Its mechanism includes: DNA cross-linking Prevention of DNA replication Inhibition of RNA synthesis Disruption of protein production Induction of apoptosis in malignant cells Since cancer cells divide much faster than healthy cells, they are more susceptible to Melphalan's effects. ALKACEL 50 mg is not self-administered. It should only be administered by trained healthcare professionals in hospitals or oncology infusion centers. Typical Treatment Process Step 1 Medical assessment Step 2 Blood investigations Step 3 Kidney function evaluation Step 4 Body surface area calculation Step 5 Dose preparation Step 6 Intravenous administration Step 7 Patient monitoring Step 8 Follow-up laboratory testing The exact dose varies according to individual patient needs and is determined by the treating oncologist. What is ALKACEL 50 mg used for? ALKACEL 50 mg is used in the treatment of certain cancers, including multiple myeloma and selected oncology indications as determined by a qualified oncologist. Is ALKACEL 50 mg a chemotherapy medicine? Yes. Melphalan is an alkylating chemotherapy medicine. Can patients administer ALKACEL 50 mg at home? No. It should only be administered by trained healthcare professionals in appropriate medical settings. Does ALKACEL 50 mg require regular blood tests? Yes. Blood counts and organ function tests are commonly monitored throughout treatment. Why Choose Primecare Impex? Primecare Impex is committed to providing quality pharmaceutical products while emphasizing accurate product information and customer support. Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130

Melalan Injection 50 mg | Anti-Cancer Injection | Product Profile | Primecare Impex Melalan Injection 50 mg – Comprehensive Product Profile Melalan Injection 50 mg is an anti-cancer medicine prescribed by qualified oncologists as part of chemotherapy treatment protocols for selected types of cancer. The medicine contains Melphalan, an alkylating agent that works by preventing the growth and multiplication of cancer cells. Treatment should always be administered under the supervision of experienced healthcare professionals in an oncology setting. Primecare Impex is committed to supplying quality pharmaceutical products while ensuring proper documentation, secure packaging, and professional customer support. Product Overview Product Name: Melalan Injection 50 mg Generic Name: Melphalan Injection Dosage Form: Injection Packing Size: 1 Vial Therapeutic Category: Anti-Cancer Medicine Administration: Hospital/Clinical Use under Medical Supervision What is Melalan Injection 50 mg? Melalan Injection 50 mg is a prescription chemotherapy medicine used in oncology for the treatment of selected cancers. It belongs to the alkylating agents group of medicines that interfere with cancer cell DNA, thereby reducing the ability of cancer cells to multiply and spread. The medicine is generally used as part of individualized chemotherapy protocols designed by oncology specialists. Melalan Injection 50 mg may be prescribed for patients diagnosed with certain cancers based on physician assessment. Clinical indications may include: • Multiple Myeloma • Ovarian Cancer (selected treatment protocols) • Conditioning therapy before bone marrow transplantation • Advanced plasma cell disorders • Certain hematological malignancies where Melphalan therapy is clinically indicated Treatment decisions depend upon: Patient age Overall health condition Kidney function Body weight Blood cell counts Cancer stage Previous chemotherapy history Patients should never self-administer this medicine. How Melalan Injection 50 mg Works Melalan Injection contains Melphalan, a potent alkylating chemotherapy agent. It works by: Binding directly to DNA inside cancer cells. Preventing DNA replication. Blocking cancer cell division. Triggering programmed cell death (apoptosis). Slowing tumour growth. Helping reduce cancer progression. Because cancer cells divide rapidly, they are particularly susceptible to this medicine. Is Melalan Injection 50 mg a chemotherapy medicine? Yes. Melalan Injection 50 mg is an anti-cancer chemotherapy medicine containing Melphalan. Can patients administer Melalan Injection at home? No. It should only be administered by qualified healthcare professionals. Is a prescription required? Yes. Melalan Injection is a prescription-only medicine. How often is treatment given? Treatment schedules vary depending on the cancer type and the oncologist's treatment plan. Can side effects be managed? Many side effects can be managed with supportive care, but patients should report any symptoms promptly to their healthcare team. Melalan Injection 50 mg should only be administered by trained healthcare professionals. Administration may include: Intravenous infusion Hospital chemotherapy unit Oncology day care centre Dosage depends upon: Cancer type Body surface area Blood investigations Kidney function Overall clinical condition Physician treatment protocol Patients should follow every scheduled appointment and laboratory investigation recommended by their oncology team. Like most chemotherapy medicines, Melalan Injection may cause side effects. Common side effects may include: Nausea Vomiting Fatigue Loss of appetite Temporary hair thinning Mouth ulcers Reduced white blood cells Reduced platelet count Increased infection risk Seek urgent medical attention if severe fever, bleeding, breathing difficulty, or allergic reactions occur. Why Choose Primecare Impex? Primecare Impex focuses on providing reliable pharmaceutical products with professional customer support. Reasons customers choose Primecare Impex include: Quality pharmaceutical products Professional customer assistance Secure packaging Timely communication International supply experience Responsive support Product documentation assistance Wide pharmaceutical product portfolio Contact Primecare Impex Primecare Impex Business Type: Exporter | Supplier | Distributor Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130 For product information, availability, and documentation, contact Primecare Impex through the above communication channels.

Leukeran Tablet 2 mg (Chlorambucil) – Complete Guide, Uses, Dosage, Safety, Side Effects & Trusted Global Supply by Primecare Impex Leukeran Tablet 2 mg (Chlorambucil) is an oral anti-cancer medicine used for chronic lymphocytic leukemia, Hodgkin lymphoma, and certain lymphomas. Learn about dosage, benefits, safety, storage, precautions, and worldwide availability through Primecare Impex serving Washington, London (UK), Riyadh (Saudi Arabia), Canberra (Australia), UAE, and Kingston (Jamaica). Leukeran Tablet 2 mg (Chlorambucil) – Complete Product Profile Leukeran Tablet 2 mg contains Chlorambucil 2 mg, a prescription oral chemotherapy medicine belonging to the alkylating agent class of anti-cancer medications. It has been used worldwide for decades in the treatment of several blood cancers and lymphatic disorders. Leukeran works by slowing or stopping the growth of cancer cells that multiply rapidly. Because of its proven clinical effectiveness, it remains an important treatment option for selected patients under the supervision of an oncologist or hematologist. Primecare Impex provides high-quality pharmaceutical export services, making genuine oncology medicines available across Washington, USA, London (UK), Riyadh (Saudi Arabia), Canberra (Australia), United Arab Emirates (UAE), and Kingston (Jamaica). Product Information Product Name: Leukeran Tablet 2 mg Generic Name: Chlorambucil Tablet 2 mg Dosage Form: Oral Tablet Strength: 2 mg Packing Size: 50 Tablets (1 Bottle) Therapeutic Category: Anti-Cancer Medicine Route of Administration: Oral Storage: Store below 25°C in a dry place away from direct sunlight. Leukeran Tablet 2 mg Leukeran Tablet 2 mg is prescribed by oncology specialists for the treatment of several cancers affecting blood and lymphatic tissues. Approved Medical Uses Chronic Lymphocytic Leukemia (CLL) Leukeran helps reduce the number of abnormal white blood cells produced in CLL. Benefits include: Reducing leukemia cell count Improving blood parameters Controlling disease progression Improving quality of life Hodgkin Lymphoma Doctors may prescribe Leukeran in selected treatment protocols for Hodgkin lymphoma. It helps: Reduce lymphoma cell growth Control swollen lymph nodes Slow disease progression Non-Hodgkin Lymphoma Leukeran is effective in treating certain slow-growing lymphomas. Benefits include: Tumor reduction Disease stabilization Improved symptom management Waldenström Macroglobulinemia Leukeran may be used to reduce abnormal immune cells responsible for this rare blood disorder. How Leukeran (Chlorambucil) Works Leukeran belongs to the alkylating agent group of chemotherapy medicines. After administration: DNA Binding Chlorambucil binds directly to the DNA inside rapidly dividing cancer cells. ↓ DNA Damage The medicine creates cross-links within DNA strands. ↓ Prevention of Cell Division Cancer cells lose the ability to divide normally. ↓ Cell Death Damaged cancer cells undergo programmed cell death (apoptosis). ↓ Reduced Tumor Growth The growth of leukemia and lymphoma cells slows significantly. Benefits of Leukeran Tablet 2 mg When prescribed appropriately, Leukeran may help: Slow cancer progression Reduce abnormal white blood cells Improve blood counts Decrease enlarged lymph nodes Relieve cancer-related symptoms Support long-term disease control in selected patients Improve overall quality of life Why Choose Primecare Impex? Primecare Impex is committed to supplying quality pharmaceutical products with a focus on reliability and customer support. Our Strengths Genuine pharmaceutical products Quality-focused sourcing Professional customer assistance Timely communication International export experience Secure packaging Transparent documentation support Responsive after-sales assistance Countries We Serve Patients and healthcare buyers frequently search for Leukeran Tablet 2 mg information in: Washington, USA London, United Kingdom Riyadh, Saudi Arabia Canberra, Australia United Arab Emirates (UAE) Kingston, Jamaica What is Leukeran Tablet 2 mg used for? It is used to treat selected blood cancers such as chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and certain types of non-Hodgkin lymphoma under medical supervision. Is Leukeran chemotherapy? Yes. Chlorambucil is an oral chemotherapy medicine belonging to the alkylating agent class. Can Leukeran cure cancer? Contact Primecare Impex Primecare Impex – Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

IFONEON 1000 MG | Ifosfamide for Injection with Mesna 1000 MG | Anti-Cancer Injection | Primecare IMPEX Learn everything about IFONEON 1000 MG (Ifosfamide for Injection with Mesna Injection 1000 MG) including uses, dosage, mechanism of action, side effects, safety, storage, and patient information. Available through Primecare IMPEX for patients and healthcare providers in Washington, London, Riyadh, Canberra, UAE, and Kingston. IFONEON 1000 MG Ifosfamide for Injection with Mesna Injection 1000 MG Advanced Anti-Cancer Injection for Chemotherapy Treatment IFONEON 1000 MG contains Ifosfamide together with Mesna, a protective medicine that helps reduce the risk of bladder damage caused by ifosfamide therapy. This medicine is prescribed by qualified oncologists as part of combination chemotherapy for several types of cancer. Treatment is administered only in hospitals or specialized cancer centers under close medical supervision. Product Profile – Understanding IFONEON 1000 MG IFONEON 1000 MG is a sterile injectable chemotherapy medicine designed for intravenous administration. The combination of Ifosfamide and Mesna provides effective cancer treatment while helping protect the urinary system from toxic metabolites produced during chemotherapy. Mesna is not an anti-cancer medicine itself. Its role is to bind harmful by-products of Ifosfamide in the urinary tract, helping lower the risk of hemorrhagic cystitis. Packing Size 1 Vial Medicine Category Anti-Cancer Medicine (Chemotherapy Injection) IFONEON 1000 MG may be prescribed by oncologists as part of treatment protocols for selected cancers, including: Soft tissue sarcoma Bone sarcoma Testicular cancer Ovarian cancer Cervical cancer Certain lymphomas Pediatric solid tumors (when recommended by pediatric oncology specialists) Other cancers where Ifosfamide-based chemotherapy is clinically appropriate The treatment plan depends on: Cancer type Stage of disease Previous chemotherapy Kidney function Liver function Blood counts Overall health condition Patients should never self-administer this medication. How IFONEON 1000 MG Works IFONEON 1000 MG works through the active ingredient Ifosfamide, an alkylating agent. Step 1 After intravenous administration, Ifosfamide is activated by liver enzymes. Step 2 The activated drug enters rapidly dividing cancer cells. Step 3 It binds to the DNA inside cancer cells. Step 4 DNA replication becomes disrupted. Step 5 Cancer cells lose their ability to multiply. Step 6 Damaged cancer cells undergo programmed cell death (apoptosis). Role of Mesna Mesna circulates through the kidneys and urinary tract, where it neutralizes toxic metabolites produced by Ifosfamide, reducing the risk of bladder injury. Only qualified healthcare professionals should administer IFONEON 1000 MG. Typical Administration Process Step 1 Medical assessment before chemotherapy. Step 2 Blood investigations. Step 3 Kidney function testing. Step 4 Liver function evaluation. Step 5 Preparation of chemotherapy under sterile conditions. Step 6 Intravenous infusion. Step 7 Adequate hydration. Step 8 Mesna administration according to protocol. Step 9 Post-treatment monitoring. The exact dose depends on: Body surface area Weight Kidney function Liver function Type of cancer Chemotherapy protocol Benefits of IFONEON 1000 MG Combination of Ifosfamide with Mesna Hospital-administered chemotherapy Used in established oncology treatment protocols Mesna helps reduce the risk of bladder toxicity associated with Ifosfamide Manufactured under quality-controlled conditions Is IFONEON 1000 MG a chemotherapy medicine? Yes. It contains Ifosfamide, an anti-cancer chemotherapy medicine, along with Mesna. Can this medicine be taken at home? No. It should only be administered in hospitals or specialized oncology centers. Why is Mesna included? Mesna helps protect the urinary bladder from toxic metabolites produced by Ifosfamide. How long does treatment last? The duration depends on the type of cancer, treatment protocol, and the patient's response, as determined by the treating oncologist. Is regular monitoring required? Yes. Blood tests and clinical monitoring are essential throughout treatment. Why Choose Primecare IMPEX Primecare IMPEX is committed to providing quality pharmaceutical products with a focus on reliability, professional service, and compliance with applicable standards. Patients and healthcare professionals choose Primecare IMPEX because of: Quality-focused pharmaceutical sourcing Reliable international supply support Professional customer assistance Timely communication Commitment to product integrity Experience in pharmaceutical exports Contact Primecare IMPEX Primecare IMPEX 🌐 Website www.medicineexporterfromindia.com 📧 Email raakeshkashiwar@gmail.com 📞 WhatsApp +91 9673008130 🔗 WhatsApp Link https://wa.me/919673008130 Business Type: Exporter | Supplier | Distributor

IFOSFAMIDE FOR INJECTION 1G | Anti Cancer Injection Exporter from India | Primecare Impex Learn everything about IFOSFAMIDE FOR INJECTION 1G, including uses, mechanism of action, dosage, side effects, storage, safety information, and regulatory details. Discover why patients and healthcare professionals trust Primecare Impex for quality pharmaceutical products. IFOSFAMIDE FOR INJECTION 1G – Complete Product Profile Cancer treatment has advanced significantly over the years, and chemotherapy medicines continue to play an important role in managing several types of cancer. IFOSFAMIDE FOR INJECTION 1G is a prescription chemotherapy medicine used under the supervision of qualified oncologists. It belongs to the alkylating agent class of anti-cancer medicines and is widely prescribed as part of combination chemotherapy protocols. Primecare Impex provides high-quality pharmaceutical products manufactured under stringent quality standards while ensuring product authenticity, regulatory compliance, and proper handling. What is IFOSFAMIDE FOR INJECTION 1G? IFOSFAMIDE FOR INJECTION 1G contains Ifosfamide, an alkylating anti-neoplastic agent used for the treatment of various cancers. It is administered intravenously by trained healthcare professionals in hospitals, oncology centers, and specialized cancer treatment facilities. The medicine works by damaging the DNA inside rapidly dividing cancer cells, thereby preventing their growth and multiplication. Product Information Product Name IFOSFAMIDE FOR INJECTION 1G Generic Name Ifosfamide Strength 1 Gram Dosage Form Sterile Powder for Injection Packing 1 Vial Category Anti Cancer Medicine Route of Administration Intravenous (IV) Prescription Status Prescription Only Medicine How IFOSFAMIDE Works IFOSFAMIDE belongs to the alkylating agents group of chemotherapy medicines. Step 1 After intravenous administration, the medicine reaches the bloodstream. Step 2 It is activated inside the liver by specific enzymes. Step 3 The active metabolites circulate throughout the body. Step 4 They enter rapidly dividing cancer cells. Step 5 The medicine forms cross-links within DNA strands. Step 6 Cancer cells lose their ability to divide. Step 7 Damaged cancer cells undergo programmed cell death (apoptosis). Step 8 Tumor growth slows down and treatment effectiveness improves when used according to oncology protocols. Only qualified healthcare professionals should administer IFOSFAMIDE FOR INJECTION 1G. Step 1 The oncologist evaluates: Medical history Kidney function Liver function Blood counts Overall health Step 2 The required dose is calculated according to: Body Surface Area (BSA) Treatment protocol Cancer type Step 3 The powder is reconstituted using sterile diluent. Step 4 Further dilution is performed using recommended infusion fluids. Step 5 The medicine is administered slowly through intravenous infusion. Step 6 Patients are monitored continuously during infusion. Step 7 Adequate hydration is maintained. Step 8 Protective medicines such as Mesna may be prescribed to reduce the risk of bladder toxicity. Why Choose Primecare Impex? Primecare Impex is committed to providing quality pharmaceutical products with a focus on reliability and customer support. Our Commitment Quality-assured pharmaceutical products Authentic manufacturer sourcing Proper packaging Reliable supply chain Experienced pharmaceutical team Responsive customer support International documentation assistance Timely communication Is IFOSFAMIDE FOR INJECTION 1G a chemotherapy medicine? Yes. It is an alkylating chemotherapy medicine used under oncology supervision. Can this medicine be used at home? No. It should only be administered by trained healthcare professionals in an appropriate medical setting. How is IFOSFAMIDE administered? It is administered by intravenous infusion after proper preparation by healthcare professionals. Does IFOSFAMIDE require regular blood tests? Yes. Regular monitoring of blood counts and organ function is an important part of treatment. Can patients continue normal activities during treatment? Activity levels vary depending on individual response and medical advice. Patients should follow their oncologist's recommendations. Contact Primecare Impex Primecare Impex – Pharmaceutical Exporter from India 🌐 Website www.medicineexporterfromindia.com 📧 Email raakeshkashiwar@gmail.com 📞 WhatsApp +91 9673008130 📲 WhatsApp https://wa.me/919673008130 Business Type Exporter | Supplier | Distributor

Learn about Hertraz Injection 440 mg (Trastuzumab Injection 440 mg), including its uses, dosage, mechanism of action, side effects, storage, and safety information. Primecare Impex is an Indian pharmaceutical exporter supplying quality medicines worldwide, including Washington, London, Riyadh, Canberra, the UAE, and Kingston. Hertraz Injection 440 mg (Trastuzumab Injection 440 mg): Complete Product Profile Hertraz Injection 440 mg (Trastuzumab Injection 440 mg): Complete Product Information Hertraz Injection 440 mg contains Trastuzumab 440 mg, a monoclonal antibody used in the treatment of certain HER2-positive cancers. It is prescribed by qualified oncologists as part of a comprehensive cancer treatment plan. Trastuzumab is designed to target cancer cells that overexpress the HER2 protein while reducing damage to healthy tissues compared with non-targeted chemotherapy. Hertraz Injection is administered only under the supervision of experienced healthcare professionals in hospitals or specialized oncology centers. Product Profile Generic Name: Trastuzumab Brand Name: Hertraz Injection 440 mg Strength: 440 mg Dosage Form: Lyophilized Powder for Injection Packing: 1 Vial Therapeutic Category: Anti-Cancer Medicine Route of Administration: Intravenous Infusion Hertraz Injection 440 mg is indicated for patients with HER2-positive cancers when prescribed by an oncology specialist. It may be used for: • HER2-positive breast cancer • Early-stage HER2-positive breast cancer • Metastatic HER2-positive breast cancer • HER2-positive metastatic gastric cancer • HER2-positive gastroesophageal junction adenocarcinoma Treatment decisions are based on laboratory confirmation of HER2-positive status before therapy begins. How Trastuzumab Works Trastuzumab is a targeted monoclonal antibody. It works by: • Recognizing HER2 receptors located on cancer cells. • Binding specifically to HER2-positive tumor cells. • Blocking signals responsible for uncontrolled tumor growth. • Activating the body's immune response against cancer cells. • Helping slow tumor progression. Because it specifically targets HER2 receptors, Trastuzumab represents a form of targeted cancer therapy. Hertraz Injection should be administered only by trained healthcare professionals. Typical treatment process: Confirm HER2-positive diagnosis. Review heart function before treatment. Reconstitute the vial according to the manufacturer's instructions. Administer through intravenous infusion. Monitor the patient during and after infusion. Continue treatment according to the oncologist's schedule. The exact dose, infusion interval, and duration depend on the patient's condition, body weight, treatment response, and clinical judgment. tore according to the manufacturer's labeling. General guidance: • Refrigerate at 2°C to 8°C. • Do not freeze. • Protect from direct light. • Keep in the original packaging. • Use reconstituted solution within the time specified by the manufacturer. • Keep out of reach of children. Why Choose Primecare Impex Primecare Impex is an Indian pharmaceutical exporter supplying quality pharmaceutical products to international markets while emphasizing product authenticity and regulatory compliance. Why many customers choose Primecare Impex: • Quality-focused pharmaceutical sourcing • Wide portfolio of pharmaceutical products • International export experience • Secure packaging practices • Responsive customer support • Assistance with export documentation • Commitment to product integrity Primecare Impex supplies pharmaceutical products to customers in many international markets, including: • Washington (USA) • London (United Kingdom) • Riyadh (Saudi Arabia) • Canberra (Australia) • United Arab Emirates (UAE) • Kingston (Jamaica) Product availability is subject to local import regulations and applicable laws. Contact Primecare Impex Primecare Impex – Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp: https://wa.me/919673008130

Herceptin 150 mg (Trastuzumab Injection 150 mg) Complete Product Profile Generic Name: Trastuzumab Brand Name: Herceptin® Strength: 150 mg Dosage Form: Lyophilized Powder for Injection Packing Size: 1 Vial Therapeutic Category: Anti-Cancer Medicine (Monoclonal Antibody) What is Herceptin 150 mg? Herceptin 150 mg contains Trastuzumab, a targeted monoclonal antibody used in the treatment of HER2-positive cancers. Unlike conventional chemotherapy, Trastuzumab specifically targets the HER2 protein found on certain cancer cells, helping slow or stop cancer growth while minimizing damage to healthy tissues. HER2-positive cancer cells produce excessive HER2 receptors, causing rapid tumor growth. Herceptin works by blocking these receptors and activating the body's immune system to destroy cancer cells. Today, Herceptin remains one of the most widely recommended targeted therapies for eligible patients diagnosed with HER2-positive breast cancer and HER2-positive gastric cancer. Herceptin 150 mg is prescribed for patients diagnosed with HER2-positive cancers after laboratory confirmation of HER2 overexpression. Breast Cancer Herceptin is indicated for: Early HER2-positive breast cancer Metastatic HER2-positive breast cancer Adjuvant treatment after surgery Neoadjuvant therapy before surgery Combination therapy with chemotherapy Maintenance treatment after chemotherapy Gastric Cancer Herceptin is also approved for: HER2-positive metastatic gastric cancer HER2-positive gastroesophageal junction adenocarcinoma Patients are treated only after confirmation through approved HER2 diagnostic testing. How Trastuzumab Works Trastuzumab is a humanized monoclonal antibody designed to specifically bind to the HER2 receptor. Step 1 HER2 receptors become overexpressed on cancer cells. ↓ Step 2 Trastuzumab attaches to the HER2 receptor. ↓ Step 3 Cancer cell signaling pathways become blocked. ↓ Step 4 Cell growth slows significantly. ↓ Step 5 The immune system recognizes and destroys HER2-positive cancer cells through antibody-dependent cellular cytotoxicity (ADCC). ↓ Step 6 Tumor progression slows while improving long-term disease control in eligible patients. Benefits of Herceptin 150 mg Herceptin has transformed treatment outcomes for HER2-positive cancers by offering targeted therapy. Key benefits include: Targets HER2-positive cancer cells specifically Reduces recurrence risk in early breast cancer Improves disease-free survival Enhances overall survival in metastatic disease Can be combined with chemotherapy Long-established safety and efficacy profile Recommended in international oncology guidelines Herceptin should only be administered under the supervision of an experienced oncology specialist. Route of Administration Intravenous infusion only. Initial Dose Loading dose: 8 mg/kg body weight Maintenance Dose 6 mg/kg every three weeks or Weekly schedule as determined by the treating oncologist. Infusion duration varies depending on patient tolerance. atients generally undergo: HER2 testing Cardiac evaluation Liver function assessment Kidney function tests Complete blood count Medical history review Because Trastuzumab may affect heart function, cardiac assessment is recommended: Before treatment During therapy After completion of treatment when clinically indicated Pregnancy Herceptin should generally be avoided during pregnancy because it may cause harm to the developing baby. Effective contraception is recommended during treatment and for a period after the final dose as advised by the treating physician. Breastfeeding Patients should discuss breastfeeding with their healthcare provider before and after treatment. Who Should Not Receive Herceptin? Treatment may not be appropriate for patients with: Severe hypersensitivity to Trastuzumab Certain serious heart conditions Uncontrolled infections Specific medical conditions identified by the treating specialist The decision should always be individualized by the healthcare provider. Why Choose Primecare Impex? Primecare Impex is committed to providing authentic pharmaceutical products with a focus on quality, reliability, and customer support. Contact Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130